Multiple Congenital Anomalies/Dysmorphic Syndrome: Unveiling the Genetic Mysteries
Explore how exome sequencing revolutionizes the diagnosis of Multiple Congenital Anomalies/Dysmorphic Syndrome, enhancing precision medicine and personalized care.
Dr. Brandon Colby, MD
MD · MBA
Founder & CEO, Sequencing.com
Founder of Sequencing and author of Outsmart Your Genes. An early voice in direct-to-consumer genetic testing.
About
About Brandon
Brandon Colby is a physician-expert in the fields of Genetic Analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University`s Graduate School of Business, and a BA with Honors in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
Education
- MD, Mount Sinai School of Medicine
- MBA, Stanford University Graduate School of Business
- BS in Genetics, with Honors, University of Michigan
Affiliations & Memberships
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Dr. Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Understanding Multiple Endocrine Neoplasia, Type 2: The Role of Genetic Testing
Explore how genetic testing aids in early detection and management of Multiple Endocrine Neoplasia Type 2, focusing on RET mutations and personalized treatment plans.
Muscle Eye Brain Disease: Unraveling Mysteries Through Genetic Testing
Explore how genetic testing aids in diagnosing Muscle Eye Brain Disease, a rare genetic disorder, facilitating early intervention and personalized treatment strategies.
Myelodysplastic Syndrome: The Role of Genetic Testing in Diagnosis and Treatment
Genetic testing revolutionizes Myelodysplastic Syndrome care by enabling early diagnosis, personalized treatment, risk stratification, and monitoring disease progression.
Myelodysplastic Syndrome with Ring Sideroblasts: Genetic Testing as a Diagnostic Beacon
Myelodysplastic syndrome with ring sideroblasts challenges diagnoses. Genetic testing identifies mutations, aiding diagnosis and personalized treatment plans effectively.
Mysteries of Myeloproliferative Neoplasm, Unclassifiable: Unraveling the Genetic Code
Explore the genetic basis of Myeloproliferative Neoplasm, Unclassifiable (MPN-U). Learn how genetic testing aids in diagnosis, treatment, and prognosis.
Myofibrillar Myopathy: Unraveling the Mysteries of Muscle Disorders Through Genetic Testing
Uncover the genetic roots of myofibrillar myopathy with genetic testing. Identify mutations like LDB3 for precise diagnosis and personalized treatment plans.
Nemaline Myopathy: Unraveling the Genetic Threads of a Muscle Disorder
Explore how genetic testing aids in diagnosing nemaline myopathy, a rare muscle disorder, offering precision in treatment, genetic counseling, and tailored care.